Recent Finacing
Recent Raise
Corstasis develops RSQ‑777, intranasal bumetanide via Unidose nasal system for short-term outpatient use in heart failure patients unresponsive to oral loop diuretics; completed animal PK and Phase I safety.
Focus Areas
Recent Investors
Funding round
Investor